Работы, цитирующие эту работу

Работ: 2

Работа: BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

1. Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone

   Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9

   СтатьяPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry2022Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.075060

2. Molecular-biological characteristics of triple negative breast cancer

   N. E. Atakhanova, Dilbar Muradovna Almuradova, I. A. Dudina

   СтатьяAdvanced Breast Cancer TherapiesRussian Journal of Biotherapy2018Цитирований: 0

   ABIABI:AkademIndex/openalex/2018.article.000554